[Epidemiology of hypertension: Differences between women and men].

Épidémiologie de l’HTA : différences femme/homme.

Journal

Presse medicale (Paris, France : 1983)
ISSN: 2213-0276
Titre abrégé: Presse Med
Pays: France
ID NLM: 8302490

Informations de publication

Date de publication:
Nov 2019
Historique:
received: 20 03 2019
accepted: 04 04 2019
pubmed: 4 6 2019
medline: 18 12 2019
entrez: 2 6 2019
Statut: ppublish

Résumé

PREVALENCE OF HYPERTENSION LESS FREQUENT IN WOMEN BEFORE MENOPAUSE: In adults, up to the age of 50-60, hypertension is an uncommon disease, less frequent in women than in men. The literature review does not determine whether this difference is related to a protective effect of endogenous estrogens on the risk of high blood pressure, to genetic or immuno-enzymatic differences related to sex but of non-hormonal origin or to a large number of confounding variables (salt consumption, alcohol consumption, fruit and vegetable consumption, body mass index, psycho-socio-economic factors, sedentary lifestyle). PREVALENCE OF HYPERTENSION INCREASES AT MENOPAUSE: After menopause, the risk of hypertension in women increases and quickly reaches that of men, even exceeding it from the seventh decade onwards. The factors that make hypertension more frequent after the seventh decade in women are related to differences in cardiovascular risk and life expectancy between men and women, as well as a likely surviving effect in older men. The mechanisms by which estrogen-progestin deficiency increases the risk of hypertension have been extensively studied. These mechanisms are obviously numerous. However, it has not been clearly demonstrated that hormone replacement therapy during menopause reduces blood pressure levels. It should be noted that the route of administration, the choice of molecules, the respect of the intervention window and the dosage seem to modulate the potential vascular effects.

Identifiants

pubmed: 31151845
pii: S0755-4982(19)30170-8
doi: 10.1016/j.lpm.2019.04.010
pii:
doi:

Substances chimiques

Estrogens 0
Sodium Chloride, Dietary 0

Types de publication

Journal Article Review

Langues

fre

Sous-ensembles de citation

IM

Pagination

1240-1243

Informations de copyright

Copyright © 2019 Elsevier Masson SAS. All rights reserved.

Auteurs

Jacques Blacher (J)

AP-HP, université Paris-Descartes, Hôtel-Dieu, centre de diagnostic et de thérapeutique, 75004 Paris, France. Electronic address: jacques.blacher@aphp.fr.

Sandrine Kretz (S)

AP-HP, université Paris-Descartes, Hôtel-Dieu, centre de diagnostic et de thérapeutique, 75004 Paris, France.

Emmanuel Sorbets (E)

AP-HP, université Paris 13, Avicenne, service de cardiologie, 93000 Bobigny, France.

Hélène Lelong (H)

AP-HP, université Paris-Descartes, Hôtel-Dieu, centre de diagnostic et de thérapeutique, 75004 Paris, France.

Alexandre Vallée (A)

AP-HP, université Paris-Descartes, Hôtel-Dieu, centre de diagnostic et de thérapeutique, 75004 Paris, France.

Marilucy Lopez-Sublet (M)

AP-HP, CHU Avicenne, université Paris 13, centre d'excellence européen en hypertension Artérielle, service de médecine interne, 93000 Bobigny, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH